Título do slide 1
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Clique aqui
Título do slide 2
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Clique aqui
Título do slide 3
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Clique aqui
Articles & Supplements
Articles & Supplements

- Relato De Caso
- DOI: 10.26790/BJO20171346A94
- 186 Views
- 0 citations
- Published in
Necrólise epidérmica tóxica associada ao uso de nivolumabe: um relato de caso pt
RESUMO Imunoterapia com nivolumabe para o tratamento de segunda linha para câncer de pulmão avançado demonstrou menor toxicidade e melhores desfechos, em comparação com quimioterapia. Quando ocorrem, os eventos adversos são geralmente imuno-mediados, podendo acometer qualquer órgão e, na maioria das vezes são manejáveis, entretanto raros casos podem ser fatais....

- Original Article
- DOI: 10.1055/s-0044-1790564
- 71 Views
- 0 citations
- Published in
Evaluation of Treatment and Recurrence-Free Survival in Patients with Early HER2-Positive Breast Cancer: Real-Life Data Comparing Public and Private Healthcare
Abstract Introduction The present study was designed to compare the treatment provided in private and public health care facilities for women positive for early breast cancer of the human epidermal growth factor receptor 2 (HER2) subtype, who received anti-HER2 therapy in neoadjuvant or adjuvant settings, with an evaluation of the recurrence-free...

- Revisão
- DOI: 10.26790/BJO20181447A175
- 21 Views
- 1 citation
- Published in
Explorando a relação entre hepatocarcinoma e o abuso de esteroides anabolizantes para otimização da aptidão física: uma revisão de literatura
ABSTRACT Introduction: Hepatocellular carcinoma (HCC) corresponds to 90% of primary malignant liver cell carcinomas and is a leading cause of cancer-related death worldwide. Objective: This compilation of cases aimed to identify evidence of correlation between anabolic androgen steroids (AAS) abuse for performance improvement by healthy subjects and HCC. Methods: We...

- Diretrizes
- DOI: 10.1055/s-0044-1792178
- 19 Views
- 0 citations
- Published in
Diretrizes brasileiras de manejo de toxicidades imunomediadas associadas ao uso de bloqueadores de correceptores imunes pt
RESUMO Nos últimos anos, assistimos à consolidação da “imunoterapia” como uma forma efetiva e viável de se tratar o câncer. Em particular, a manipulação terapêutica de moléculas envolvidas na modulação da resposta imune com o uso de anticorpos monoclonais, ou bloqueadores de correceptores imunes, viabilizou uma nova realidade para pacientes...

- Case Report
- DOI: 10.5935/2526-8732.20200040
- 18 Views
- 1 citation
- Published in
Melanoma peniano
ABSTRACT Penile melanoma is a rare event, responsible for less than 1.4% of penile cancers. In general, it is late diagnosed and the treatment is usually aggressive. The authors present a 66-year-old Caucasian man who had an ulcerated penile lesion for 1 year, diagnosed as melanoma after biopsy and treated...

- Review Article
- DOI: 10.5935/2526-8732.20230373
- 16 Views
- 0 citations
- Published in
Personalized medicine: overview and comparison of challenges and opportunities for its implementation in the Brazilian public healthcare system (SUS)
ABSTRACT The objective of this work is, through a literature review, to promote the debate on personalized medicine and acquire a broad view of the subject and its tools from the perspective of oncology, disseminate the topic, support, and encourage initiatives to implement its technologies in the Brazilian public healthcare...

- Relato De Caso
- DOI: 10.26790/BJO20171346A94
- 14 Views
- 0 citations
- Published in
Necrólise epidérmica tóxica associada ao uso de nivolumabe: um relato de caso pt
RESUMO Imunoterapia com nivolumabe para o tratamento de segunda linha para câncer de pulmão avançado demonstrou menor toxicidade e melhores desfechos, em comparação com quimioterapia. Quando ocorrem, os eventos adversos são geralmente imuno-mediados, podendo acometer qualquer órgão e, na maioria das vezes são manejáveis, entretanto raros casos podem ser fatais....

- Artigo Original
- DOI: 10.26790/BJO20181447A197
- 13 Views
- 1 citation
- Published in
FOLFIRINOX para adenocarcinoma de pâncreas avançado: experiência institucional
ABSTRACT Objective: Data is lacking about FOLFIRINOX use for advanced pancreatic ductal adenocarcinoma in emerging countries. The objective of this study was to report outcomes of efficacy and safety in the setting of a South American institution. Methods: Patients treated with FOLFIRINOX for metastatic or locally advanced pancreatic cancer at...

- Case Report
- DOI: 10.1055/s-0045-1812295
- 13 Views
- 0 citations
- Published in
The Potential of Hypofractionated Radiotherapy: A Revolutionary Treatment for Anorectal Malignant Melanomas
Abstract Mucosal melanomas generally arise from mucosal epithelium lining the respiratory, alimentary, and genitourinary tracts and usually carry worse prognosis than cutaneous melanomas. Anorectal melanomas account for 50% of gastrointestinal tract melanomas and 0.3 to 1% of all malignant melanomas. There are no specific treatment guidelines due to the scarcity...

- Case Report
- DOI: 10.1055/s-0045-1812295
- 13 Views
- 0 citations
- Published in
The Potential of Hypofractionated Radiotherapy: A Revolutionary Treatment for Anorectal Malignant Melanomas
Abstract Mucosal melanomas generally arise from mucosal epithelium lining the respiratory, alimentary, and genitourinary tracts and usually carry worse prognosis than cutaneous melanomas. Anorectal melanomas account for 50% of gastrointestinal tract melanomas and 0.3 to 1% of all malignant melanomas. There are no specific treatment guidelines due to the scarcity...

- Original Article
- DOI: 10.1055/s-0044-1790564
- 71 Views
- 0 citations
- Published in
Evaluation of Treatment and Recurrence-Free Survival in Patients with Early HER2-Positive Breast Cancer: Real-Life Data Comparing Public and Private Healthcare
Abstract Introduction The present study was designed to compare the treatment provided in private and public health care facilities for women positive for early breast cancer of the human epidermal growth factor receptor 2 (HER2) subtype, who received anti-HER2 therapy in neoadjuvant or adjuvant settings, with an evaluation of the recurrence-free...

- Original Article
- DOI: 10.1055/s-0044-1790564
- 71 Views
- 0 citations
- Published in
Evaluation of Treatment and Recurrence-Free Survival in Patients with Early HER2-Positive Breast Cancer: Real-Life Data Comparing Public and Private Healthcare
Abstract Introduction The present study was designed to compare the treatment provided in private and public health care facilities for women positive for early breast cancer of the human epidermal growth factor receptor 2 (HER2) subtype, who received anti-HER2 therapy in neoadjuvant or adjuvant settings, with an evaluation of the recurrence-free...

- Original Article
- DOI: 10.1055/s-0044-1787970
- 10 Views
- 0 citations
- Published in
Lawsuits against the Brazilian Unified Health System regarding Bladder/Ureteral Cancer
Abstract Objective To evaluate the technical notes (TNs) issued by the Center for Technical Support of the Judiciary (Núcleo de Apoio Técnico do Poder Judiciário, NAT-Jus, in Portuguese) of the Brazilian Ministry of Justice regarding lawsuits against the Brazilian Unified Health System (Sistema Único de Saúde, SUS, in Portuguese) concerning bladder/ureteral...
2020 | SBOC – AACR Joint Congress: A Translational Approach to Clinical Oncology
Location: Virtual Meeting
Date: October 30, 2020
2019 | XXI Congresso da Sociedade Brasileira de Radioterapia (SBRT)
Location: Hotel Windsor Barra, in Rio de Janeiro (RJ)
Date: October 23, 2019
2019 | XIV Congresso Brasileiro de Cirurgia Oncológica
Location: Windsor Barra Hotel Rio de Janeiro/RJ
Date: October 23, 2019
2018 | XX Congresso da Sociedade Brasileira de Radioterapia
Location: Belo Horizonte
Date: August 15, 2018
2017 | I Semana Brasileira de Oncologia
Location: Rio de Janeiro
Date: October 24, 2017
Search for articles
News